Ganoderic acid Mk
IUPAC name: (E)-5-acetoxy-6-(3-acetoxy-15-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-hept-2-enoic acid
CAS Number: 110024-14-1
Class: Terpenoid
Mushrooms contain this compound
1 mushrooms
| MushID |
Thai name |
Common name |
Scientific name |
Family |
| 1 |
เห็ดหลินจือ |
Lingzhi |
Ganoderma lucidum ( Curtis ) P. Karst. |
Ganodermataceae |
2D Structure
Compound Properties
SMILES
CC(=O)OC(C(C1CC(C2(C1(C)CC=C1C2=CCC2C1(C)CCC(C2(C)C)OC(=O)C)C)O)C)C/C=C(/C(=O)O)\C
Physicochemical Properties
| Formula |
C34H50O7 |
| Molecular wieght(g/mol) |
570.76 |
| Num. of Heavy atoms |
41 |
| Num. of Aromatic Heavy atoms |
0 |
| Fraction Csp3 |
0.74 |
| Num. of Rotatable bonds |
9 |
| Num. of H-bond acceptors |
7 |
| Num. of H-bonds donors |
2 |
| Molar Refractivity |
160.14 |
| TPSA (square Angstrom) |
110.13 |
Lipophilicity
| iLOGP |
3.97 |
| XLOGP3 |
5.96 |
| WLOGP |
6.40 |
| MLOGP |
4.54 |
| Silicos-IT LOGP |
5.77 |
| Consensus LOGP |
5.33 |
Water Solubility
| ESOL |
|
| LogS |
-6.54 |
Solubility(mg/ml) |
1.65E-04 |
Solubility(mol/l) |
2.89E-07 |
Class |
Poorly soluble |
| Ali |
|
| LogS |
-8.05 |
Solubility(mg/ml) |
5.10E-06 |
Solubility(mol/l) |
8.94E-09 |
Class |
Poorly soluble |
| Silicos-IT |
|
| LogS |
-5.12 |
Solubility(mg/ml) |
4.33E-03 |
Solubility(mol/l) |
7.59E-06 |
Class |
Moderately soluble |
Pharmacokinetics
| GI absorbtion |
Low |
| BBB permeant |
No |
| Pgp substrate |
Yes |
| CYP1A2 inhibitor |
No |
| CYP2C19 inhibitor |
No |
| CYP2C9 inhibitor |
No |
| CYP2D6 inhibitor |
No |
| CYP3A4 inhibitor |
Yes |
| Log Kp (skin permeation) (cm/s) |
-5.55 |
Druglikeness
| Lipinski Num. violations |
2 |
| Ghose Num. violations |
4 |
| Veber Num. violations |
0 |
| Egan Num. violations |
1 |
| Muegge Num. violations |
1 |
| Bioavailability Score |
0.56 |
Medicinal Chemistry
| PAINS Num. of alerts |
0 |
| Brenk Num. of alerts |
2 |
| Leadlikeness Num. of violations |
3 |
| Synthetic Accessibility |
6.91 |
Biological Activity
| Biological Activity |
JID |
| Antitumour |
6 |
| Anti-angiogenic |
6 |
| Anti-HIV |
6 |
| Antihistaminic |
6 |
| Anti hepatotoxic |
6 |
| Complement inhibition |
6 |
| Hypocholesterolemic |
6 |
| Antiplatelet aggregation |
6 |
